Cover Image

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy

Saved in:
Bibliographic Details
Main Authors: Aichler, Michaela (Author) , Ott, Katja (Author)
Format: Article (Journal)
Language:English
Published: August 2014
In: OncoTarget
Year: 2014, Volume: 5, Issue: 16, Pages: 6620-6632
ISSN:1949-2553
DOI:10.18632/oncotarget.2268
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.18632/oncotarget.2268
Get full text
Author Notes:Michaela Aichler, Martin Motschmann, Uta Jütting, Birgit Luber, Karen Becker, Katja Ott, Florian Lordick, Rupert Langer, Marcus Feith, Jörg Rüdiger Siewert and Axel Walch

MARC

LEADER 00000caa a2200000 c 4500
001 1527153185
003 DE-627
005 20220812172641.0
007 cr uuu---uuuuu
008 160304s2014 xx |||||o 00| ||eng c
024 7 |a 10.18632/oncotarget.2268  |2 doi 
035 |a (DE-627)1527153185 
035 |a (DE-576)457153180 
035 |a (DE-599)BSZ457153180 
035 |a (OCoLC)1340902093 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Aichler, Michaela  |d 1977-  |e VerfasserIn  |0 (DE-588)136784135  |0 (DE-627)587249137  |0 (DE-576)287406601  |4 aut 
245 1 0 |a Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy  |c Michaela Aichler, Martin Motschmann, Uta Jütting, Birgit Luber, Karen Becker, Katja Ott, Florian Lordick, Rupert Langer, Marcus Feith, Jörg Rüdiger Siewert and Axel Walch 
264 1 |c August 2014 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.03.2016 
700 1 |a Ott, Katja  |d 1971-  |e VerfasserIn  |0 (DE-588)118131257  |0 (DE-627)079261914  |0 (DE-576)291731244  |4 aut 
773 0 8 |i Enthalten in  |t OncoTarget  |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010  |g 5(2014), 16, Seite 6620-6632  |h Online-Ressource  |w (DE-627)63035975X  |w (DE-600)2560162-3  |w (DE-576)325343764  |x 1949-2553  |7 nnas  |a Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy 
773 1 8 |g volume:5  |g year:2014  |g number:16  |g pages:6620-6632  |g extent:13  |a Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy 
856 4 0 |u http://dx.doi.org/10.18632/oncotarget.2268  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20160304 
993 |a Article 
994 |a 2014 
998 |g 118131257  |a Ott, Katja  |m 118131257:Ott, Katja  |d 910000  |d 910200  |e 910000PO118131257  |e 910200PO118131257  |k 0/910000/  |k 1/910000/910200/  |p 6 
999 |a KXP-PPN1527153185  |e 2901842690 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 04.03.2016"],"recId":"1527153185","name":{"displayForm":["Michaela Aichler, Martin Motschmann, Uta Jütting, Birgit Luber, Karen Becker, Katja Ott, Florian Lordick, Rupert Langer, Marcus Feith, Jörg Rüdiger Siewert and Axel Walch"]},"language":["eng"],"id":{"eki":["1527153185"],"doi":["10.18632/oncotarget.2268"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"August 2014","dateIssuedKey":"2014"}],"relHost":[{"disp":"Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapyOncoTarget","note":["Gesehen am 16.08.2018"],"pubHistory":["1.2010,Mai -"],"recId":"63035975X","origin":[{"dateIssuedKey":"2010","publisher":"Impact Journals LLC","dateIssuedDisp":"2010-","publisherPlace":"[Erscheinungsort nicht ermittelbar]"}],"id":{"issn":["1949-2553"],"zdb":["2560162-3"],"eki":["63035975X"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"OncoTarget","subtitle":"open access impact journal","title_sort":"OncoTarget"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"16","year":"2014","extent":"13","pages":"6620-6632","text":"5(2014), 16, Seite 6620-6632","volume":"5"}}],"title":[{"title":"Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy","title_sort":"Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy"}],"person":[{"role":"aut","given":"Michaela","display":"Aichler, Michaela","family":"Aichler"},{"given":"Katja","family":"Ott","display":"Ott, Katja","role":"aut"}],"physDesc":[{"extent":"13 S."}]} 
SRT |a AICHLERMICEPIDERMALG2014 

Similar Items